The clinical indicator is a tool used to monitor the quality of health care. Its use in the Intensive Care Unit (ICU) is desirable for many reasons: the maintenance of minimum standards, the development of best practice and the delivery of cost-effective health care. The utility of clinical indicators in ICU is limited by the lack of universal, robust, transparent, evidence-based and risk-adjusted measures of quality, and the difficulties in defining "quality care" and "good outcome". Monitoring of adverse events, system descriptors, and resource indicators is valuable but they have a limited relationship to the quality of care. ICU mortality prediction models provide a global measure of quality and, despite their inherent deficiencies, remain one of the most robust and useful clinical indicators.
The clinical indicator can be considered the health care equivalent of the key performance indicator in commercial business. The impetus for the use of clinical indicators has arisen, at least in part, from the observation that all human systems including health care 1, 2 are fallible, and from the elusive search for objective measures of quality.
Clinical indicators are sought for many reasons. Policy-makers seek to identify a minimum acceptable standard of health care 3 and prevent the recurrence of the Bristol 4 and Shipman 5 phenomena. Hospital administrators seek a cost-effective health care system. Clinicians seek to improve professional standards and patient care, and their business managers seek to convince the policy-makers and administrators that they deserve the funding to do so.
Can the clinical indicator live up to these expectations? Will manipulation and misuse of (clinical indicator) data lead to cynicism rather than improvement in the quality of patient care? Do we place unrealistic expectations upon the validity of clinical indicators? Is the clinical indicator an overrated quality tool?
What is quality health care? Quality is difficult to define and difficult to quantify. It is often described by the terms excellence and best practice but this only begs the definition of these terms. On the other hand, it is easier to identify and measure a lack of quality. The occurrence of iatrogenic and preventable morbidity and mortality are indicative of a deficiency in quality. Hence most clinical indicators are proscriptive and focus on adverse events.
The need to identify and measure quality of care is just as important for intensive care medicine [6] [7] [8] [9] as it is in any other area of health care. Intensive care medicine is resource and labour intensive, and its clients are often complex and at high risk of adverse events-drug errors, procedural failures, therapeutic complications, delayed diagnosis or intervention, management errors, communication deficiencies, and death.
INHERENT LIMITATIONS OF CLINICAL INDICATORS
It is unlikely that the ideal characteristics (Table 1 ) will ever be found in one clinical indicator. All clini-cal indicators have substantive limitations. This is exemplified by some of the recently proposed ACHS 3, 9 indicators for intensive care medicine ( Table  2) . What are some of these limitations?
Clinical indicators are based upon the premise that there is substantial uniformity in, and repetition of, disease patterns. Consequently, outcomes can be compared between groups of patients and between institutions, and common standards of acceptable care can be determined. However, diversity is the reality-no two patients are truly alike -and the "classic" or archetypical case of a disease or syndrome does not exist. There is infinite variability in presentations, and even where similarity exists there are many equally effective management strategies. This is epitomized only too well in the practice of intensive care medicine where patients often have complex multi-system disease. To counter this limitation in quality measurement tools it is necessary to utilize (a) appropriate inclusion and exclusion criteria, and (b) adjustment for the type of patient treated (casemix).
Clinical indicators presume a deterministic or reductionist model of disease, where the relationship between cause and effect is clear-each adverse outcome has an identifiable (and hopefully preventable) antecedent. Only in such a system is it possible to conclude that prevention of the antecedent will improve quality of care. For example, iatrogenic morbidity often leads to an increase in Intensive Care Unit (ICU) length of stay (LOS) 10 , so it follows that LOS may be a potentially useful measure of quality.
Unfortunately even the more simple clinical indicators have a complex and multifactorial aetiology, and lack a sufficient evidence base to justify their use.
Even where data appears to exist, the statistical linking of an apparent "cause" with an effect (eg. on patient outcome) does not prove causality. For example, although LOS is increased by iatrogenic morbidity, it is also decreased by death-critically ill patients who die in hospital have a shorter LOS than those who survive. Thus LOS (the proposed clinical indicator) may be longer in those units with better quality of care and better survival rates. Many such indicators lack sufficient information about what they are measuring.
Clinical indicators also tend to focus on short-term outcomes and deflect attention away from long-term or global improvements in standards. Thus an increase in an (apparent) adverse event rate does not necessarily indicate a fall in standards, but may in fact be linked with an overall improvement in care.
For example, an indicator such as "unexpected extubation" will be lower in an ICU that uses excessive sedation. As a consequence, morbidity (from prolonged mechanical ventilation), hospital length of stay and costs will be greater. Excessive or unnecessary use of physical restraint devices will also decrease the prevalence of "unexpected extubation" but this is not necessarily an improvement in quality of patient care.
Nor is death necessarily a bad outcome. For the most part intensive care medicine seeks to reduce mortality risk and where possible return patients to full health. Death is thus seen as an unambiguous adverse outcome. However, when it becomes clear that an illness is irreversible -the patient is dyingwithdrawal of life-support therapy is humane and more appropriate than the prolongation of futile therapy or a vegetative state. Triage of these patients is compounded by the absence of accurate outcome prediction tools, necessitating the admission to ICU of patients who will not ultimately survive (e.g. patients with severe hypoxic encephalopathy.) Some would also argue that, even when death is inevitable, admission to an ICU to provide time for grieving families and the provision of palliative care is also high quality care.
Conversely, survival is not synonymous with quality. Survival and discharge from hospital might be a "failure" from the perspective of the patient and family if functional status and quality of life are unacceptably impaired. Further research into medium- and long-term outcomes following ICU discharge is therefore required. Clinical indicators often suffer from a low "signalto-noise" ratio. Low frequency events, such as pneumothorax following insertion of a central venous catheter, may ignore major deficiencies in other aspects of care. For example, an ICU that mandates the femoral or internal jugular route is likely to have few, if any, pneumothoraces, but a higher prevalence of nosocomial line sepsis than a Unit that uses the subclavian route. Thus it is important to identify adverse events that reflect a wide range of clinical practices.
High frequency events (e.g. insertion of central venous catheter) with low complication rates (pneumothorax) require resource-intensive data collection systems where the benefits and results of these efforts hardly justify the expense. A low event rate may encourage either a false sense of security or cynicism about the value of monitoring quality of care. Thus it is preferable to monitor adverse events that are frequent enough to generate useful conclusions and justify the resources required to collect the data.
Creative data manipulation is a temptation in all quality activities. It may be deliberate (to exaggerate or conceal) or it may be inadvertent. Imprecise definitions, incomplete data, poor quality data, or misinterpretation will all lead to misleading results.
For example, the inability to admit to an Intensive Care Unit (Table 2 ) may be over-or under-reported 11 depending upon the definitions, methodology and motives behind the reporting system used. To minimize "creative" reporting of clinical indicators, transparent and robust definitions and methodologies are essential.
Clinical indicators should be prescriptive, not simply descriptive. Many proposed indicators (such as throughput, length of stay, staffing levels, casemix, crude mortality, etc.) are more accurately defined as activity descriptors 12 . Some activity descriptors (e.g. throughput, casemix, LOS, staffing) are important for funding purposes 13 but they have little or no correlation with quality of care. The ANZICS Research Centre for Critical Care Resources reports 14, 15 exemplify this distinction-they provide excellent detailed data regarding the magnitude and distribution of intensive care resources across Australian States and New Zealand, but give no indication of the quality of care provided.
A fall in quality of care may produce an unequivocal change in an activity descriptor (e.g., morbidity increases LOS) that makes that descriptor appear to behave as a quality indicator. However, the reverse conclusion (that LOS is a measure of quality of care) does not necessarily apply. As noted above, an increase in LOS may reflect unavoidable changes in casemix or complexity, whereas a decrease in LOS may be the result of inappropriately high rates of premature-discharge rate or death. Clinical indicators should provide clear information about what they are seeking to measure. Activity descriptors include "indicators" 9 that are primarily organizational, structural, resource, and process measures. They may be statistically linked to outcome, mimicking the appearance of a clinical indicator, but they do not measure quality of care independent of the organizational, structural, resource, or process variable. They may be helpful in explaining why there is a difference in outcome but (unlike outcome-based, therapy-independent, quality indicators) they cannot evaluate quality of care. Activity descriptors provide useful insights into what is "best practice" but have a limited ability to evaluate better practice.
Some activity descriptors of access to ICU are potentially useful as indicators of resource allocation and distribution within a health care system 16, 17 . For example, inability to admit to an Intensive Care Unit data indicates when service demand exceeds the resources available. Although it describes an outcome that has nothing to do with the quality of care delivered to those who are admitted, it may be considered as a quality indicator of the health care system and the provision of critical care services within that system. Other examples of ICU resource indicators include major surgery cancellation, delayed admission, and premature discharge rates. Table 3 provides a list of clinical indicators for critical care services and a summary of their relevance and limitations.
CLINICAL INDICATORS IN ICU
Further consideration of outcome scoring systems and mortality prediction models is warranted here. Simplistically, these models have been developed by collecting information from a large number of ICU patients, and observing how many die. Logistic regression is then used to see which variables predict death or survival, and to derive an equation (or model) that describes the relationship between the predictor variables (like blood pressure) and mortality.
Many mortality prediction models are available for use in intensive care 18 (See text.)
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ing or shortly after admission, and have a number of strengths as clinical indicators 24, 25 . The standardized mortality rate (SMR) is calculated by dividing the number of patients who actually died in an ICU by the number of deaths predicted by the mortality prediction model -an SMR less than unity suggests the ICU is doing better than predicted, and an SMR greater than unity suggests it is doing worse than predicted. In effect, the SMR compares the number of deaths that actually occurred with the number that would have occurred if the same patients had been looked after in the units that derived the score (at the time the score was derived).
The most commonly used outcome prediction methodologies have been validated in large cohorts of critically ill patients in many countries. They enable benchmarking on regional, national and international levels. The outcome measure (i.e. death) is robust, unequivocal, common, and therefore relevant. The data is relatively easy to collect and the algorithms are freely available. Most incorporate adjustments for severity of illness and casemix. Furthermore the outcome measure (hospital survival) reflects the quality of care of critically ill patients across the institution (not simply within the walls of the ICU).
These scoring systems carry important caveats 26, 27 and, like all clinical indicators are prone to misunderstanding and abuse. Some of these include: a) Data inaccuracy: The validity of the results is entirely dependent upon accurate data collection. This requires the use of properly trained data collectors with adequate validation of the data. b) Historical bias: The models are based on historical populations, and benchmarking with contemporaneous populations is required. The weighting coefficients become outdated and require recalibration every few years. c) Exclusivity: Some important patient groups (e.g. cardiac surgery and burns) are excluded from some models. d) Population base: The results are only applicable to large groups and cannot be used as a quality measure for the management of individual patients. e) Mathematical coupling: The APACHE and SAPS models include a number of therapy-dependent variables to predict (therapy-dependent) outcome. On the other hand, the MPM and PIM systems are based on therapy-independent variables 28 . f) Bias: Mortality prediction models do not adjust for all factors that affect survival (e.g. source of referral 29 , pre-admission transfer 11, 30, 31 , nocturnal discharge 31, 32 , delayed admission 33 , and premature discharge 32, 34 ). g) Benchmarking with other institutions or countries is complex and prone to over-simplification 26 . Despite these deficiencies, mortality prediction models 24 remain one of the most robust and useful clinical indicators. Few other craft groups within health care can claim to have such a broad and robust measure of the quality of care.
Mortality prediction models are sometimes criticised because they focus on mortality rather than morbidity. Monitoring of adverse events and morbidity is also very important. However, it seems reasonable to assume that ICUs that deliver poor quality of care and have above average morbidity will also have increased mortality detectable by a mortality prediction model.
Although adverse events such as pneumothorax and unplanned extubation are undesirable, there is little benefit in collecting this information unless it adds to the performance of the mortality prediction model. For example, pneumothorax and unplanned extubation do not add to the performance of PIM 23high rates of these adverse events reflects poor quality of care, but this is detected by the other variables in the model.
Until recently, it has been difficult to know what period of time to include in each analysis of the SMR for a particular ICU. CUSUM analysis 35 is a powerful statistical technique that allows the plotting of sequential risk-adjusted mortality data over time. Movement of an individual plot outside predetermined limits provides an early warning that the process or system under review is moving away from acceptable control values. Steiner has described the use of risk adjusted CUSUM charts to monitor surgical perfomance 36 . The use of risk adjusted data (such as the APACHE II or III scoring systems) for CUSUM analysis may provide a statistically valid method of monitoring individual ICU performance across a heterogenous case-mix 37 . The validity of CUSUM analysis depends on the validity of the mortality prediction model used to derive the expected mortality rate.
CONCLUSION
The clinical indicator may be viewed as a marker of quality deficiency. It may be used to identify a minimum standard of practice and set the boundary conditions that flag possible deficiencies in care -perhaps in the same way that statutory laws identify unacceptable behaviour, but set no limits on what is acceptable behaviour.
In the light of the significant philosophical and practical limitations to clinical indicators, it is important to acknowledge that they can only be one part of a spectrum of quality activities. At best, they act as an imprecise warning system to flag possible outliers or issues for further investigation. Clinical indicators should be outcome-based, not simply descriptive (e.g. resource, structural or process indicators) and evaluate quality of care independent of therapy or organizational factors.
Further research is required in many of these areas, not the least of which is the fundamental question of what constitutes "good quality" care and how best to measure both immediate and long-term outcomes. We need to address the questions: What outcomes define quality of care? Which "clinical indicators" are good predictors of (an improvement or a decline in) quality of care? And what process is required to translate raw (clinical indicator) data into improved outcomes?
